Pharmafile Logo
Pharmafocus logo
Advanced Search
800px-rhesus_macaque_monkey_the_look

Pfizer-BioNTech reports strong immune response in animals to its COVID-19 vaccine

September 10, 2020
Research and Development COVID, Macaques, Monkey, Vaccine

Pfizer-BioNTech announced Wednesday that preliminary preclinical data from mouse and macaque monkey models showed a strong immune response from its …

News
bob_woodward_meets_with_edward_r

President Trump has misled the public on how deadly COVID-19 is, according to Watergate reporter’s tapes

September 10, 2020
Medical Communications All the President's men, Bob Woodward, Trump, Watergate

President Trump knew how much more deadly coronavirus was than the flu, despite public comments saying that the threat of …

News
covid_cell_1_1

Pharmafile.com’s weekly COVID-19 news round-up

September 10, 2020
Business Services

The coronavirus news this week focuses on lockdowns and infections, as England is set to increase lockdown restrictions across the …

News
steen-klysner-jpeg-1

Industry veteran Dr Steen Klysner appointed as Amarna’s new CEO

September 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amarna, appointments

Amarna Therapeutics has announced the appointment of a new Chief Executive Officer (CEO), hiring industry veteran Dr Steen Klysner to …

Appointment
1

Ali Fattaey appointed Chief Executive Officer of MetaboMed

September 9, 2020
Research and Development

MetaboMed has appointed Ali Fattaey, Ph.D. as its new Chief Executive Officer.Fattaey has over 20 years experience in the industry. …

Appointment
alexion_sign

Alexion’s Ondexxya approved for NHS Scotland to treat uncontrolled and life-threatening bleeds

September 9, 2020
Research and Development, Sales and Marketing Alexion, NHS, Ondexxya, Scotland, nhs scotland

The Scottish Medicines Consortium (SMC) has given its recommendation to Alexion’s Ondexxya (andexanet alfa) to routine use on NHS Scotland …

News

AstraZeneca slams brakes on COVID-19 vaccine trial over unexplained participant illness

September 9, 2020
Research and Development AstraZeneca, COVID-19, pharma

Global trials for AstraZeneca’s much-hyped COVID-19 vaccine, currently in development in partnership with the University of Oxford, have been halted …

News
800px-informal_meeting_of_ministers_for_foreign_affairs_gymnich

Gatherings of over six people to be banned in England from Monday

September 9, 2020
Research and Development Lockdown, coronavirus

England is set to increase lockdown restrictions across the country after a surge in coronavirus cases.  Currently, most outdoor gatherings …

News
download_1

Roche to start new trials of Ocrevus to defend multiple sclerosis franchise

September 9, 2020
Research and Development MS, MS drug, Roche

Roche is to begin expanding trials of Ocrevus in multiple sclerosis (MS) patients to defend its MS franchise from its …

News
china_v_0_1

Major vaccine manufacturers sign COVID-19 safety pledge

September 9, 2020
Research and Development CDC, FDA, anti vaxx, anti-vaxx, coronavirus vaccine

Nine vaccine manufactures have signed a pledge to uphold ethical standards while producing their treatments for COVID-19.  The companies involved …

News
carter_percy

FibroGen names appointment for newly created Chief Scientific Officer role

September 8, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, fibrogen

FibroGen has created the new role of Chief Scientific Officer and appointed Dr Percy Carter to the position, it has …

Appointment
molly_henderson

Advaxis Chief Financial Officer resigns

September 8, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Advaxis

Molly Henderson, the Chief Financial Officer and Executive Vice President of Advaxis, has announced her resignation that will take effect …

Appointment
shutterstock_512649

Takeda to sell another non-core portfolio for $260 million to Cheplapharm

September 8, 2020
Manufacturing and Production, Sales and Marketing Cheplapharm, Takeda, pharma

Takeda has revealed it has agreed to divest its non-core portfolio of prescription therapies to Cheplapharm in exchange for an …

News
sanofi_hq__boetie_hall_web

Extension study reveals Dupixent’s benefit can last up to three years in moderate-to-severe asthma

September 8, 2020
Manufacturing and Production, Research and Development Dupixent, Sanofi, asthma, pharma

New findings have been revealed from an extension study of Sanofi’s interleukin-4 (IL-4) and interleukin-13 (IL-13) inhibitor Dupixent (dupilumab) in …

News
800px-mono-embolex_by_danny_s

Mylan reaches agreement with Aspen for their European thrombosis business

September 8, 2020
Manufacturing and Production Mylan, aspen

Mylan has announced an agreement to acquire the intellectual property and commercialisation rights to Aspen’s thrombosis business for €641.9 million.  …

News
china_v

Chinese drug firm says thousands have been vaccinated for COVID-19 on an emergency use scheme

September 8, 2020
Manufacturing and Production China Vaccine, China Vaccine approval, coronavirus vaccine

Hundreds of thousands of people in China have been inoculated with two experimental vaccines on an emergency use scheme, according …

News
800px-thumbnail_1

Up to 60,000 in the UK may have suffered from “long COVID” new data suggests

September 8, 2020
Manufacturing and Production Vaccine, pandemic, vaccines

60,000 people across Britain may have been suffering from prolonged symptoms of coronavirus months after contracting the virus. This is …

News
genentech_web

Genetech scores sixth FDA approval in lung cancer with Gavreto

September 7, 2020
Sales and Marketing Cancer, FDA, Genentech, lung cancer

Genentech’s once-daily oral therapy Gavreto (pralsetinib) has secured FDA backing in the treatment of metastatic rearranged during transfection (RET) fusion-positive …

News
800px-sanofi_frankfurt_iph

President of Sanofi France expects COVID-19 vaccine to be priced below ten Euros

September 7, 2020
Sales and Marketing COVID-19, GSK, Sanofi

The President of Sanofi France expects the coronavirus vaccine it is developing with GlaxoSmithKline to be priced under 10 Euros.  …

News
janssen_latest_logo_on_sign

Janssen’s Imbruvica secures label expansion in Europe in chronic lymphocytic leukaemia

September 7, 2020
Sales and Marketing Europe, Janssen, imbruvica, pharma

The European Commission (EC) has moved to expand the existing approval of Janssen’s Imbruvica (ibrutinib) in chronic lymphocytic leukaemia (CLL) …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025